• Business Areas

    Medical Imaging

    For clinical trials (Phase 1–4) utilizing medical imaging as a part of efficacy endpoints assessment, Tigermed offers specialized professional medical imaging services.

    Imaging Modality and Disease Indication

    ?         Modality includes CT, MRI, PET, PET/CT, SPECT, X-ray, DSA, US/Echo, Endoscopy and digital photos etc.

    ?         Therapeutic Areas: Oncology, Cardiovascular Disease, CNS, Hematology, Musculoskeletal Diseases, Digestive Disease, Dermatology, Ophthalmology, Medical Device, Contrast Agent, etc. 

    Scope of service

    ?         Imaging acquisition protocol design

    ?         Medical imaging requirement consultation   

    ?         Site imaging acquisition capability evaluation     

    ?         Off-Site/On-site training and support

    ?         Collecting and managing independent imaging QC  

    ?         Anonymization electronic system – LUX system for site’s imaging data transmission

    ?         Real-time image evaluation for patient enrollment eligibility

    ?         Consultation service for the efficacy evaluation criteria (e.g. modified RECIST)

    ?         Independent Radiology Review Charter development  

    ?         Designing and programming imaging EDC (IEES-Imaging Electronic Evaluation System) 

    ?         Managing and conducting independent imaging efficacy evaluation and analysis   

    ?         Imaging data management plans

    ?         Delivery of the imaging analysis results to client or pertinent trial approval agent

    ?         Complete trial supporting documentation and audit trail


    ?         Offering professional radiology guidance throughout the entire clinical trial

    ?         Process strictly adheres to FDA/NMPA guidance 

    ?         Standard oncology packages that significantly reduce developing time and cost

    ?         Multiple options of independent reads for clients to meet specific end-points needs of clinical trials

    ?         Validated review systems designed specifically for clinical trials

    ?         Auditable and reproducible reviewing results

    ?         Significant reduction of evaluation variability and keeping a complete database record and storage

    ?         Remote reading capability

    ?         Working with designated clinical CRO closely to ensure the reliable and accurate final trial results which incorporate all pertinent information.

    Independent Reading Criteria

    ?         RECIST (1.0, 1.1) and modified RECIST

    ?         Cheson / IWGC

    ?         RANO

    ?         WHO

    ?         SHARP

    ?         Tumor Volume or Area Calculation

    ?         Organ volume Measurement

    ?         Others

    Fill In Your Project Requirements Or Contact Us

    Usage of Cookies

    The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy .

    Tigermed is strongly committed to corporate compliance on both a local and global level. You may report concerns to Tigermed confidentially and anonymously at Compliance Concern on matters related to Tigermed’s business activities.